Aridis Pharmaceuticals, Inc. (ARDS)

OTCMKTS: ARDS · Delayed Price · USD
0.0772
+0.0002 (0.26%)
Feb 29, 2024, 2:31 PM EST - Market open

Aridis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Revenue
0011.022.760.862.27
Revenue Growth (YoY)
---2.15%-62.93%220.58%-62.10%-
Cost of Revenue
0000001.93
Gross Profit
0011.022.760.860.34
Selling, General & Admin
7.167.316.456.033.873.161.97
Research & Development
25.9237.9416.9624.082317.446.26
Other Operating Expenses
-3.09-1.5400000
Operating Expenses
29.9943.7123.430.1126.8720.68.23
Operating Income
-29.99-43.71-22.4-29.09-24.12-19.74-7.88
Interest Income
000.08000.230
Interest Expense
0.38-0.25000.4200.37
Other Expense / Income
--0.270.010.59-4.860.23-0.37
Pretax Income
-30.37-43.19-22.33-29.68-22.11-24.66-8.42
Income Tax
0.38-0.91-0.41-0.72.434.920.54
Net Income
-30.75-42.28-21.92-28.99-22.11-24.66-8.42
Shares Outstanding (Basic)
191298388
Shares Outstanding (Diluted)
191298388
Shares Change
52.77%34.06%8.40%168.80%-60.12%--
EPS (Basic)
-1.64-3.44-2.39-3.43-7.02-3.12-1.07
EPS (Diluted)
-1.64-3.44-2.39-3.43-7.02-3.12-1.07
Free Cash Flow
-29.21-23.47-20.84-8.33-24.95-18.26-6.11
Free Cash Flow Per Share
-1.56-1.91-2.27-0.99-7.93-2.31-0.77
Gross Margin
--100.00%100.00%100.00%100.00%15.07%
Operating Margin
---2240.10%-2846.09%-874.76%-2295.12%-347.47%
Profit Margin
---2191.90%-2836.20%-801.78%-2866.98%-371.18%
Free Cash Flow Margin
---2084.30%-815.36%-904.90%-2122.67%-269.11%
EBITDA
-29.51-44.43-22.4-29.09-25.75-14.52-7.69
EBITDA Margin
---2240.10%-2846.09%-933.95%-1688.84%-338.87%
Depreciation & Amortization
0.490.440.340.340.280.060.02
EBIT
-29.99-44.87-22.74-29.43-26.03-14.59-7.71
EBIT Margin
---2273.80%-2879.16%-944.21%-1696.05%-339.89%
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.